/PLUN.ST
PLUN.ST Stock - ProstaLund AB (publ)
Healthcare|Medical - Care FacilitiesSTO
$0.21-35.15%
$0.12 (-35.15%) • Oct 31
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.24
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PLUN.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.21 – $0.22
TARGET (TP)$0.25
STOP LOSS$0.20
RISK/REWARD1:2.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.26
52W High$11.88
52W Low$0.15
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $13.72M | $22.21M | $17.41M | $17.07M | $12.46M |
| Gross Profit | $8.87M | $15.65M | $12.87M | $14.68M | $9.54M |
| Gross Margin | 64.6% | 70.5% | 73.9% | 86.0% | 76.6% |
| Operating Income | $-22,490,000 | $-16,851,000 | $-10,893,000 | $-7,855,000 | $-9,919,000 |
| Net Income | $-22,631,000 | $-17,010,000 | $-11,303,000 | $-7,919,000 | $-10,041,000 |
| Net Margin | -164.9% | -76.6% | -64.9% | -46.4% | -80.6% |
| EPS | $-0.56 | $-0.25 | $-0.21 | $-0.17 | $-0.26 |
Company Overview
ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PLUN.STBeat Rate
67%
Last 12 quarters
Avg Surprise
+50.4%
EPS vs Estimate
Beats / Misses
8/4
Last 12 quarters
Latest EPS
$-0.08
Q4 2025
EPS Surprise History
Q2 23
+94.3%
$-0.07vs$-1.14
Q3 23
+92.8%
$-0.08vs$-1.14
Q4 23
+96.2%
$-0.04vs$-1.15
Q1 24
+91.9%
$-0.06vs$-0.77
Q2 24
+91.8%
$-0.09vs$-1.15
Q3 24
+96.8%
$-0.04vs$-1.15
Q4 24
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 7, 2025 | — | $-0.08 | — | — |
Q2 2025 | May 30, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.06 | — | — |
Q3 2024 | Sep 30, 2024 | $-1.15 | $-0.04 | +96.8% | ✓ BEAT |
Q2 2024 | Jun 29, 2024 | $-1.15 | $-0.09 | +91.8% | ✓ BEAT |
Q1 2024 | Mar 30, 2024 | $-0.77 | $-0.06 | +91.9% | ✓ BEAT |
Q4 2023 | Dec 30, 2023 | $-1.15 | $-0.04 | +96.2% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $-1.14 | $-0.08 | +92.8% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $-1.14 | $-0.07 | +94.3% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $-1.14 | $-0.06 | +95.1% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | $-0.76 | $-0.05 | +92.9% | ✓ BEAT |
Q3 2022 | Sep 30, 2022 | $-0.04 | $-0.04 | -5.6% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $-0.04 | $-0.07 | -89.2% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-0.03 | $-0.04 | -40.0% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-0.04 | — | — |
Q3 2021 | Sep 30, 2021 | $-0.03 | $-0.03 | -11.8% | ✗ MISS |
Q2 2021 | Jun 30, 2021 | — | $-0.06 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.03 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.09 | — | — |
Q4 2020 | Oct 23, 2020 | — | $-0.09 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PLUN.ST
What is PLUN.ST's current stock price?
ProstaLund AB (publ) (PLUN.ST) is currently trading at $0.21 per share. The stock has moved -35.15% today.
What is the analyst price target for PLUN.ST?
No analyst price targets are currently available for this stock.
What sector is ProstaLund AB (publ) in?
ProstaLund AB (publ) operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the STO exchange.
What is PLUN.ST's market cap?
ProstaLund AB (publ) has a market capitalization of $0.00 billion, making it a small-cap company.
Does PLUN.ST pay dividends?
No, ProstaLund AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACARIX.ST
Acarix AB (publ)
$0.28
Mkt Cap: $0.3B
AMBEA.ST
Ambea AB (publ)
$141.30
Mkt Cap: $11.9B
ATT.ST
Attendo AB (publ)
$81.90
Mkt Cap: $12.4B
BACK
IMAC Holdings, Inc.
$0.14
Mkt Cap: $0.0B
EPIS-B.ST
Episurf Medical AB (publ)
$0.03
Mkt Cap: $0.0B
HUM.ST
Humana AB (publ)
$49.65
Mkt Cap: $2.4B
SCIB.ST
SciBase Holding AB (publ)
$0.36
Mkt Cap: $0.1B
SEZI.ST
Senzime AB (publ)
$5.26
Mkt Cap: $0.8B
Explore stocks similar to PLUN.ST for comparison